Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer

PURPOSE OF REVIEW: HER2-targeted therapies have led to improved clinical outcomes in early and advanced breast cancer (BC). We review the long-term cardiotoxicity of HER2-targeted therapy in early and advanced BC, our current knowledge of cardiotoxicity of novel HER2-targeted therapies, and propose...

Descripción completa

Detalles Bibliográficos
Autores principales: Dent, Susan F., Morse, Amber, Burnette, Sarah, Guha, Avirup, Moore, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Cardio-oncology (EH Yang, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395382/
https://www.ncbi.nlm.nih.gov/pubmed/34453232
http://dx.doi.org/10.1007/s11912-021-01114-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395382/
https://www.ncbi.nlm.nih.gov/pubmed/34453232
http://dx.doi.org/10.1007/s11912-021-01114-x

Ejemplares similares